La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « effects »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
effectiveness < effects < efferents  Facettes :

List of bibliographic references indexed by effects

Number of relevant bibliographic references: 290.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000010 (2017) Mahshad Kolahdouzan [Canada] ; Mazen J. Hamadeh [Canada]The neuroprotective effects of caffeine in neurodegenerative diseases.
000025 (2017) Soha Alomar [Arabie saoudite] ; Nicolas K K. King [Canada] ; Joseph Tam [Canada] ; Ausaf A. Bari [États-Unis] ; Clement Hamani [Canada] ; Andres M. Lozano [Canada]Speech and language adverse effects after thalamotomy and deep brain stimulation in patients with movement disorders: A meta-analysis.
000094 (2017) Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada]Effects of progesterone administered after MPTP on dopaminergic neurons of male mice.
000095 (2017) Holly A. Fernandes [Canada] ; Norman W. Park [Canada] ; Quincy J. Almeida [Canada]Effects of practice and delays on learning and retention of skilled tool use in Parkinson's disease.
000172 (2016) Jenny Advocat ; Joanne Enticott ; Brooke Vandenberg ; Craig Hassed ; Jennifer Hester [Australie] ; Grant RussellThe effects of a mindfulness-based lifestyle program for adults with Parkinson’s disease: a mixed methods, wait list controlled randomised control study
000251 (2016) Katherine Coulombe [Canada] ; Martine Saint-Pierre [Canada] ; Giulia Cisbani [Canada] ; Isabelle St-Amour [Canada] ; Claire Gibrat [Canada] ; Ariane Giguère-Rancourt [Canada] ; Frédéric Calon [Canada] ; Francesca Cicchetti [Canada]Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.
000269 (2016) Alencar Kolinski Machado [Brésil] ; Ana Cristina Andreazza [Canada] ; Tatiane Morgana Da Silva [Brésil] ; Aline Augusti Boligon [Brésil] ; Vanusa Do Nascimento [Brésil] ; Gustavo Scola [Canada] ; Angela Duong [Canada] ; Francine Carla Cadoná [Brésil] ; Euler Esteves Ribeiro [Brésil] ; Ivana Beatrice Mânica Da Cruz [Brésil]Neuroprotective Effects of Açaí (Euterpe oleracea Mart.) against Rotenone In Vitro Exposure
000299 (2016) Josée Savard [Canada] ; Hans Ivers [Canada] ; Marie-Hélène Savard [Canada] ; Charles M. Morin [Canada]Long-Term Effects of Two Formats of Cognitive Behavioral Therapy for Insomnia Comorbid with Breast Cancer
000355 (2016) Tiago A. Mestre [Canada] ; Anthony E. Lang [Canada] ; Michael S. Okun [États-Unis]Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects.
000373 (2016) Keith A. Wesnes [Royaume-Uni, Australie] ; Carl Gommoll [États-Unis] ; Changzheng Chen [États-Unis] ; Angelo Sambunaris [Géorgie (pays)] ; Roger S. Mcintyre [Canada] ; Philip D. Harvey [États-Unis]Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study
000503 (2015) Christina Tremblay [Canada] ; Joël Macoir [Canada] ; Mélanie Langlois [Canada] ; Léo Cantin [Canada] ; Michel Prud'Homme [Canada] ; Laura Monetta [Canada]The effects of subthalamic deep brain stimulation on metaphor comprehension and language abilities in Parkinson's disease.
000572 (2015) Dongsun Park [Corée du Sud] ; Kyungha Shin [Corée du Sud] ; Ehn-Kyoung Choi [Corée du Sud] ; Youngjin Choi [Corée du Sud] ; Ja-Young Jang [Corée du Sud] ; Jihyun Kim [Corée du Sud] ; Heon-Sang Jeong [Corée du Sud] ; Wooryoung Lee [Corée du Sud] ; Yoon-Bok Lee [Corée du Sud] ; Seung Up Kim [Canada] ; Seong Soo Joo [Corée du Sud] ; Yun-Bae Kim [Corée du Sud, Canada]Protective Effects of N-Acetyl-L-Cysteine in Human Oligodendrocyte Progenitor Cells and Restoration of Motor Function in Neonatal Rats with Hypoxic-Ischemic Encephalopathy
000579 (2015) R T Bartus [États-Unis] ; J H Kordower [États-Unis] ; E M Johnson [États-Unis] ; L. Brown [États-Unis] ; B R Kruegel [États-Unis] ; Y. Chu [États-Unis] ; T L Baumann [États-Unis] ; A E Lang [Canada] ; C W Olanow [États-Unis] ; C D Herzog [États-Unis]Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.
000619 (2015) Hooman Ganjavi [Canada] ; Penny A. MacdonaldON-OFF Effects of Dopaminergic Therapy on Psychiatric Symptoms in Parkinson's Disease.
000629 (2015) Jinghua Liu ; Arjun H. Banskota ; Alan T. Critchley ; Jeff Hafting ; Balakrishnan PrithivirajNeuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease
000636 (2015) Soojin Lee [Canada] ; Diana J. Kim [Canada] ; Daniel Svenkeson [États-Unis] ; Gabriel Parras [États-Unis] ; Meeko Mitsuko K. Oishi [États-Unis] ; Martin J. Mckeown [Canada]Multifaceted effects of noisy galvanic vestibular stimulation on manual tracking behavior in Parkinson’s disease
000731 (2015) Zaijun Zhang [République populaire de Chine] ; Guohui Li [République populaire de Chine] ; Samuel S W. Szeto [République populaire de Chine] ; Cheong Meng Chong [République populaire de Chine] ; Quan Quan [République populaire de Chine] ; Chen Huang [République populaire de Chine] ; Wei Cui [République populaire de Chine] ; Baojian Guo [République populaire de Chine] ; Yuqiang Wang [République populaire de Chine] ; Yifan Han [République populaire de Chine] ; K W Michael Siu [Canada] ; Simon Ming Yuen Lee [République populaire de Chine] ; Ivan K. Chu [République populaire de Chine]Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease.
000744 (2015) Sang Jin Kim ; Kaviraja Udupa ; Zhen Ni ; Elena Moro ; Carolyn Gunraj ; Filomena Mazzella ; Andres M. Lozano ; Mojgan Hodaie ; Anthony E. Lang ; Robert ChenEffects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease
000745 (2015) Filsy Samuel ; William P. Flavin ; Sobia Iqbal ; Consiglia Pacelli ; Sri Dushyaanthan Sri Renganathan ; Louis-Eric Trudeau ; Edward M. Campbell [États-Unis] ; Paul E. Fraser ; Anurag Tandon [Canada]Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization*
000765 (2015) Ziv Gan-Or ; Idan Amshalom ; Laura L. Kilarski ; Anat Bar-Shira ; Mali Gana-Weisz ; Anat Mirelman ; Karen Marder ; Susan Bressman ; Nir Giladi ; Avi Orr-UrtregerDifferential effects of severe vs mild GBA mutations on Parkinson disease
000798 (2015) Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Igor Tatarnikov [Canada] ; Patrick Chou [Canada] ; Sabrina Bergeron [Canada] ; Emma Mitchell [Canada] ; Roscoe Lim [Canada] ; Jaskaran Khinda [Canada] ; Alejandro Lloret [États-Unis] ; C Frank Bennett [États-Unis] ; Carmela Paradiso [Italie] ; Michele Morari [Italie] ; Matthew J. Farrer [Canada] ; Austen J. Milnerwood [Canada]Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.
000812 (2015) Isabelle Beaulieu-Boire [Canada] ; Anthony E. LangBehavioral effects of levodopa.
000867 (2014) Fariborz Rahimi [Iran] ; Carina Bee [Canada] ; Christian Duval [Canada] ; Patrick Boissy [Canada] ; Roderick Edwards [Canada] ; Mandar Jog [Canada]Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease.
000903 (2014) Danielle K. Murray [Canada] ; Matthew A. Sacheli [Canada] ; Janice J. Eng [Canada] ; A Jon Stoessl [Canada]The effects of exercise on cognition in Parkinson’s disease: a systematic review
000904 (2014) Magda Osman [Royaume-Uni] ; Agata Ryterska [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; Lingling Tu [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
000A06 (2014) Antonio Cerasa [Italie] ; Alfonso Fasano [Canada] ; Francesca Morgante [Italie] ; Giacomo Koch [Italie] ; Aldo Quattrone [Italie]Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology
000A09 (2014) Lucia Ricciardi [Royaume-Uni] ; Carla Piano [Italie] ; Anna Rita Bentivoglio [Italie] ; Alfonso Fasano [Canada]Long-term effects of pedunculopontine nucleus stimulation for Pisa syndrome.
000A72 (2014) Ji Hyun Ko [États-Unis, Canada] ; Renata P. Lerner [États-Unis] ; David Eidelberg [États-Unis]Effects of Levodopa on Regional Cerebral Metabolism and Blood Flow
000A73 (2014) Alexandra Nadeau [Canada] ; Emmanuelle Pourcher ; Philippe CorbeilEffects of 24 wk of treadmill training on gait performance in Parkinson's disease.
000B14 (2014) Jean-Francois Esculier [Canada] ; Joanie Vaudrin [Canada] ; Louis E. Tremblay [Canada]Corticomotor excitability in Parkinson's disease during observation, imagery and imitation of action: effects of rehabilitation using wii fit and comparison to healthy controls.
000B45 (2014) Deepak Mittal ; Arabella Young ; Kimberley Stannard ; Michelle Yong ; Michele W L. Teng ; Bertrand Allard [Canada] ; John Stagg [Canada] ; Mark J. Smyth [Australie]Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor.
000B54 (2014) Lilian Calder N-Garcidue As [États-Unis] ; Ricardo Torres-Jard N [Mexique] ; Randy J. Kulesza [États-Unis] ; Su-Bin Park [Canada] ; Amedeo D'Angiulli [Canada]Air pollution and detrimental effects on children's brain. The need for a multidisciplinary approach to the issue complexity and challenges.
000B58 (2014) Pieter-Jan Maes [Canada] ; Marc Leman [Belgique] ; Caroline Palmer [Canada] ; Marcelo M. Wanderley [Canada]Action-based effects on music perception
000B60 (2014) Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada]AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys.
000B82 (2014) Magda Osman [Royaume-Uni] ; Agata Rytersk [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; LINGLING TU [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]The effects of dopaminergic medication on dynamic decision making in Parkinson's disease
000C01 (2014) Alexandra Nadeau [Canada] ; Emmanuelle Pourcher [Canada] ; Philippe Corbeil [Canada]Effects of 24 wk of Treadmill Training on Gait Performance in Parkinson's Disease
000C11 (2014) Deepak Mittal [Australie] ; Arabella Young [Australie] ; Kimberley Stannard [Australie] ; Michelle Yong [Australie] ; Michele W. L. Teng [Australie] ; Bertrand Allard [Canada] ; John Stagg [Canada] ; Mark J. Smyth [Australie]Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
000C50 (2013) James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. BrotchieThe effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
000C55 (2013) Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Ramachandiran Nandhagopal [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada]The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling
000D87 (2013) R. Abdalian [Canada] ; O. Saqui ; G. Fernandes ; J P AllardEffects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.
000D88 (2013) Yang Gao [Irlande (pays)] ; R Nán O'Caoimh [Irlande (pays)] ; Liam Healy [Irlande (pays)] ; David M. Kerins [Irlande (pays)] ; Joseph Eustace [Irlande (pays)] ; Gordon Guyatt [Canada] ; David Sammon [Irlande (pays)] ; D William Molloy [Irlande (pays), Canada]Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia
000E00 (2013) Elizabeth I. Cawley ; Sarah Park ; Marije Aan Het Rot ; Kimberley Sancton ; Chawki Benkelfat ; Simon N. Young ; Diane B. Boivin ; Marco LeytonDopamine and light: dissecting effects on mood and motivational states in women with subsyndromal seasonal affective disorder
000E01 (2013) Susanne Becker [Canada, Allemagne] ; Marta Ceko [États-Unis] ; Mytsumi Louis-Foster [Canada] ; Nathaniel M. Elfassy [Canada] ; Marco Leyton [Canada] ; Yoram Shir [Canada] ; Petra Schweinhardt [Canada]Dopamine and Pain Sensitivity: Neither Sulpiride nor Acute Phenylalanine and Tyrosine Depletion Have Effects on Thermal Pain Sensations in Healthy Volunteers
000E05 (2013) Alex A. Macdonald [Canada] ; Ken N. Seergobin [Canada] ; Adrian M. Owen [Canada] ; Ruzbeh Tamjeedi [Canada] ; Oury Monchi [Canada] ; Hooman Ganjavi [Canada] ; Penny A. Macdonald [Canada]Differential Effects of Parkinson's Disease and Dopamine Replacement on Memory Encoding and Retrieval
000E90 (2013) Melissa A. Mckinney [Canada] ; Sara J. Iverson [Canada] ; Aaron T. Fisk [Canada] ; Christian Sonne [Danemark] ; Frank F. Rigét [Danemark] ; Robert J. Letcher [Canada] ; Michael T. Arts [Canada] ; Erik W. Born ; Aqqalu Rosing-Asvid ; Rune Dietz [Danemark]Global change effects on the long‐term feeding ecology and contaminant exposures of East Greenland polar bears
000F79 (2013) Vjera Holthoff [Allemagne] ; Steven Ferris [États-Unis] ; Serge Gauthier [Canada] ; Ralf Ihl [Allemagne] ; Philippe Robert [France] ; Bengt Winblad [Suède] ; Kati Sternberg [Allemagne] ; Frank Tennigkeit [Suisse]Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open‐label, single‐arm, multicenter clinical study
001026 (2013) Anand I. Rughani [États-Unis, Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada]Acute complications of movement disorders surgery: Effects of age and comorbidities
001037 (2013) Roger S. Mcintyre [Canada] ; Alissa M. Powell [Canada] ; Oksana Kaidanovich-Beilin [Canada] ; Joanna K. Soczynska [Canada] ; Mohammad Alsuwaidan [Canada] ; Hanna O. Woldeyohannes [Canada] ; Ashley S. Kim [Canada] ; L. Ashley Gallaugher [Canada]The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
001038 (2013) James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001048 (2013) D. Lee [États-Unis] ; D. Y. Henriques [Canada] ; J. Snider [États-Unis] ; D. Song [États-Unis] ; H. Poizner [États-Unis]REACHING TO PROPRIOCEPTIVELY DEFINED TARGETS IN PARKINSON'S DISEASE: EFFECTS OF DEEP BRAIN STIMULATION THERAPY
001049 (2013) Erin R. Foster [États-Unis] ; Mark A. Mcdaniel [États-Unis] ; Nathan S. Rose [Canada] ; Peter G. Rendell [Australie]Prospective Memory in Parkinson Disease During a Virtual Week: Effects of Both Prospective and Retrospective Demands

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "effects" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "effects" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    effects
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022